Large-scale testing (Phase 3)Ended earlyNCT04644029
What this trial is testing
Oral ISL QM as PrEP in Cisgender Women at High Risk for HIV-1 Infection (MK-8591-022)
Who this might be right for
HIV-IHuman Immunodeficiency Virus Type 1Prophylaxis
Merck Sharp & Dohme LLC 730